| Name | Title | Contact Details |
|---|---|---|
Dhiraj Sankala |
Chief Technology Officer | Profile |
For more than 100 years, VNA Health Group`s visiting nurses of NJ have made a difference in people`s lives Compassionate, caring, patient-centered, home- and community-based care delivered to you by people who take the time to know you, not just your medical history. We bring advanced care to where you`re most comfortable and can heal the fastest— in your home or wherever you reside. Each year, as the largest, non-profit visiting nurse association in New Jersey, our inter-disciplinary team provide services to more than 120,000 of your neighbors and friends, perhaps even you or someone you love. We are proud to know that we help make our community a healthier place. Whether it`s providing care for children with special needs or in-home care for seniors, we can help.
Impact Cryotherapy is the national leader in designing and manufacturing whole body cryotherapy systems. The company`s state-of-the-art cryosaunas are sleek, attractive single-person chambers that are engineered and manufactured in the United States in an ISO 9001 certified facility. Impact Cryotherapy is redefining the age-old technique of cryotherapy with advanced technology and aesthetics to deliver unmatched efficiency, comfort and reliability.
Global Healthcare Resource is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SciTec is a company that provides cutting edge advancements for defense, security, and civil affairs. Their team is committed to delivering advanced sensor systems, data processing algorithms, and testing equipment for defense, national security, and c...
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.